8-K: Procter & Gamble Reports Mixed Q2 Results: Sales Up, Earnings Impacted by Impairment

Procter & Gamble's second quarter fiscal year 2024 saw a 3% increase in net sales and a 4% rise in organic sales, but diluted EPS decreased by 12% due to a non-cash impairment charge.

Summary

• Procter & Gamble (P&G) announced its second quarter fiscal year 2024 results, with net sales reaching $21.4 billion, a 3% increase compared to the previous year.
• Organic sales, which exclude the impact of foreign exchange and acquisitions/divestitures, grew by 4%.
• Diluted earnings per share (EPS) decreased by 12% to $1.40, primarily due to a $1.3 billion non-cash impairment charge related to the Gillette intangible asset.
• Core EPS, which excludes the impact of the impairment and restructuring charges, increased by 16% to $1.84.
• Operating cash flow was $5.1 billion, and net earnings were $3.5 billion for the quarter.
• Adjusted free cash flow productivity was 95%, calculated as operating cash flow excluding capital spending, as a percentage of net earnings excluding the Gillette impairment charge.
• The company returned $3.3 billion to shareholders through $2.3 billion in dividends and $1 billion in share repurchases.
• Gross margin increased by 520 basis points, or 590 basis points on a currency-neutral basis, driven by productivity savings, favorable commodity costs, and increased pricing.
• The company is undergoing a limited market portfolio restructuring, primarily in certain Enterprise Markets, which is expected to result in $1.0 to $1.5 billion in after-tax restructuring charges over fiscal years 2024 and 2025.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to strong sales growth and core EPS increase, but the significant impairment charge and restructuring costs temper the overall outlook. The raised core EPS guidance is a positive sign, but the lowered diluted EPS guidance is a concern.

Positives

• Net sales increased by 3% year-over-year.
• Organic sales grew by 4% year-over-year.
• Core EPS increased by 16% year-over-year.
• Gross margin improved significantly by 520 basis points.
• The company is returning significant cash to shareholders through dividends and share repurchases.
• P&G raised its core EPS growth guidance for fiscal year 2024 to 8% to 9%.

Negatives

• Diluted EPS decreased by 12% due to a $1.3 billion non-cash impairment charge on the Gillette intangible asset.
• The company is undergoing a limited market portfolio restructuring, which will result in significant restructuring charges.
• Organic shipment volumes decreased by 1% in the quarter.
• Foreign exchange is expected to be a headwind of approximately one to two percentage points to all-in sales growth for fiscal year 2024.
• The company lowered its fiscal 2024 diluted net earnings per share growth from a range of 6% to 9% to a range of -1% to in-line versus fiscal 2023 EPS of $5.90.

Risks

• The company faces risks related to global financial risks, including foreign currency fluctuations and economic volatility.
• There are risks associated with managing disruptions in credit markets and maintaining key manufacturing and supply arrangements.
• The company is exposed to risks related to cost fluctuations, including commodity prices and labor costs.
• There are risks related to competition, changing consumer habits, and technological advances.
• The company faces risks related to regulatory and legal requirements, including product liability and environmental regulations.
• The company is exposed to risks related to the war between Russia and Ukraine.
• The company is exposed to risks related to achieving its environmental sustainability priorities.

Future Outlook

P&G maintained its fiscal year 2024 sales growth guidance of 2% to 4% and organic sales growth guidance of 4% to 5%. The company adjusted its fiscal 2024 diluted net earnings per share growth from a range of 6% to 9% to a range of -1% to in-line versus fiscal 2023 EPS of $5.90. P&G raised its fiscal 2024 core net earnings per share growth from a range of 6% to 9% to a range of 8% to 9% versus fiscal 2023 EPS.

Management Comments

• We delivered strong results in the second quarter, enabling us to raise our core EPS growth guidance and maintain our top-line outlook for the fiscal year, said Jon Moeller, Chairman of the Board, President and Chief Executive Officer.
• We remain committed to our integrated strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority across product performance, packaging, brand communication, retail execution and consumer and customer value productivity, constructive disruption and an agile and accountable organization.
• The P&G teams execution of this strategy has enabled us to build and sustain strong momentum.
• We have confidence this remains the right strategy to deliver balanced growth and value creation.

Industry Context

The results reflect a mixed performance in the consumer goods sector, with strong sales growth offset by significant one-time charges. The company's focus on pricing and premium products aligns with industry trends, but the restructuring and impairment charges highlight the challenges of managing global operations and brand valuations.

Comparison to Industry Standards

• P&G's 4% organic sales growth is a solid performance compared to some of its peers in the consumer goods industry, such as Unilever, which has reported similar organic sales growth in recent quarters.
• The 16% increase in core EPS is a strong result, but the 12% decrease in diluted EPS due to the Gillette impairment is a significant negative factor.
• Colgate-Palmolive, another major player in the consumer goods sector, has also been focusing on pricing and premium products to drive growth, similar to P&G's strategy.
• The restructuring charges are not uncommon in the industry as companies adjust to changing market conditions and economic challenges, similar to recent restructuring announcements by other large consumer goods companies.
• The 95% adjusted free cash flow productivity is a strong indicator of P&G's ability to generate cash, which is a key metric for investors in the consumer goods sector.

Stakeholder Impact

• Shareholders will be impacted by the decrease in diluted EPS but will benefit from the increased core EPS and continued dividends and share repurchases.
• Employees may be affected by the limited market portfolio restructuring.
• Customers may see changes in product availability in the affected markets.
• Suppliers may be impacted by the restructuring and changes in the company's operations.
• Creditors will be impacted by the company's financial performance and restructuring activities.

Next Steps

• The company will continue to execute its integrated strategy.
• The company will implement the limited market portfolio restructuring.
• The company will continue to focus on productivity improvements and cost savings.
• The company will continue to return cash to shareholders through dividends and share repurchases.

Key Dates

Keywords

Procter & Gamble, P&G, Earnings, Net Sales, Organic Sales, EPS, Core EPS, Gillette, Impairment, Restructuring, Dividends, Share Repurchases, Gross Margin, Free Cash Flow